vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $379.6M, roughly 1.8× DIVERSIFIED HEALTHCARE TRUST). Natera, Inc. runs the higher net margin — 7.1% vs -5.6%, a 12.7% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -0.0%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-166.4M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 1.2%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

DHC vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.8× larger
NTRA
$665.5M
$379.6M
DHC
Growing faster (revenue YoY)
NTRA
NTRA
+39.8% gap
NTRA
39.8%
-0.0%
DHC
Higher net margin
NTRA
NTRA
12.7% more per $
NTRA
7.1%
-5.6%
DHC
More free cash flow
NTRA
NTRA
$204.3M more FCF
NTRA
$37.8M
$-166.4M
DHC
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
1.2%
DHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DHC
DHC
NTRA
NTRA
Revenue
$379.6M
$665.5M
Net Profit
$-21.2M
$47.3M
Gross Margin
Operating Margin
-12.6%
-3.4%
Net Margin
-5.6%
7.1%
Revenue YoY
-0.0%
39.8%
Net Profit YoY
75.7%
187.9%
EPS (diluted)
$-0.09
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
NTRA
NTRA
Q4 25
$379.6M
$665.5M
Q3 25
$388.7M
$592.2M
Q2 25
$382.7M
$546.6M
Q1 25
$386.9M
$501.8M
Q4 24
$379.6M
$476.1M
Q3 24
$373.6M
$439.8M
Q2 24
$371.4M
$413.4M
Q1 24
$370.8M
$367.7M
Net Profit
DHC
DHC
NTRA
NTRA
Q4 25
$-21.2M
$47.3M
Q3 25
$-164.0M
$-87.5M
Q2 25
$-91.6M
$-100.9M
Q1 25
$-9.0M
$-66.9M
Q4 24
$-87.4M
$-53.8M
Q3 24
$-98.7M
$-31.6M
Q2 24
$-97.9M
$-37.5M
Q1 24
$-86.3M
$-67.6M
Operating Margin
DHC
DHC
NTRA
NTRA
Q4 25
-12.6%
-3.4%
Q3 25
-43.4%
-16.5%
Q2 25
-24.5%
-20.2%
Q1 25
-2.7%
-15.8%
Q4 24
-26.1%
-13.6%
Q3 24
-26.5%
-8.9%
Q2 24
-23.0%
-10.6%
Q1 24
-23.7%
-20.2%
Net Margin
DHC
DHC
NTRA
NTRA
Q4 25
-5.6%
7.1%
Q3 25
-42.2%
-14.8%
Q2 25
-23.9%
-18.5%
Q1 25
-2.3%
-13.3%
Q4 24
-23.0%
-11.3%
Q3 24
-26.4%
-7.2%
Q2 24
-26.3%
-9.1%
Q1 24
-23.3%
-18.4%
EPS (diluted)
DHC
DHC
NTRA
NTRA
Q4 25
$-0.09
$0.36
Q3 25
$-0.68
$-0.64
Q2 25
$-0.38
$-0.74
Q1 25
$-0.04
$-0.50
Q4 24
$-0.37
$-0.41
Q3 24
$-0.41
$-0.26
Q2 24
$-0.41
$-0.30
Q1 24
$-0.36
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$105.4M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$1.7B
$1.7B
Total Assets
$4.4B
$2.4B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
NTRA
NTRA
Q4 25
$105.4M
Q3 25
$201.4M
$1.0M
Q2 25
$141.8M
$16.0M
Q1 25
$302.6M
$17.8M
Q4 24
$144.6M
$22.7M
Q3 24
$256.5M
$29.5M
Q2 24
$265.6M
$90.3M
Q1 24
$207.1M
$69.1M
Total Debt
DHC
DHC
NTRA
NTRA
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
NTRA
NTRA
Q4 25
$1.7B
$1.7B
Q3 25
$1.7B
$1.3B
Q2 25
$1.9B
$1.2B
Q1 25
$1.9B
$1.2B
Q4 24
$2.0B
$1.2B
Q3 24
$2.0B
$878.5M
Q2 24
$2.1B
$836.5M
Q1 24
$2.2B
$794.1M
Total Assets
DHC
DHC
NTRA
NTRA
Q4 25
$4.4B
$2.4B
Q3 25
$4.7B
$1.8B
Q2 25
$4.8B
$1.8B
Q1 25
$5.0B
$1.7B
Q4 24
$5.1B
$1.7B
Q3 24
$5.3B
$1.6B
Q2 24
$5.3B
$1.5B
Q1 24
$5.3B
$1.5B
Debt / Equity
DHC
DHC
NTRA
NTRA
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
NTRA
NTRA
Operating Cash FlowLast quarter
$-19.6M
$73.9M
Free Cash FlowOCF − Capex
$-166.4M
$37.8M
FCF MarginFCF / Revenue
-43.8%
5.7%
Capex IntensityCapex / Revenue
38.7%
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$-280.3M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
NTRA
NTRA
Q4 25
$-19.6M
$73.9M
Q3 25
$-49.3M
$59.4M
Q2 25
$53.0M
$37.6M
Q1 25
$-3.2M
$44.5M
Q4 24
$112.2M
$52.9M
Q3 24
$21.1M
$51.8M
Q2 24
$44.3M
$4.0M
Q1 24
$28.6M
$27.0M
Free Cash Flow
DHC
DHC
NTRA
NTRA
Q4 25
$-166.4M
$37.8M
Q3 25
$-89.8M
$37.0M
Q2 25
$18.8M
$11.7M
Q1 25
$-42.9M
$22.6M
Q4 24
$-89.5M
$34.8M
Q3 24
$-26.1M
$35.5M
Q2 24
$3.3M
$-7.7M
Q1 24
$-18.1M
$6.7M
FCF Margin
DHC
DHC
NTRA
NTRA
Q4 25
-43.8%
5.7%
Q3 25
-23.1%
6.2%
Q2 25
4.9%
2.1%
Q1 25
-11.1%
4.5%
Q4 24
-23.6%
7.3%
Q3 24
-7.0%
8.1%
Q2 24
0.9%
-1.9%
Q1 24
-4.9%
1.8%
Capex Intensity
DHC
DHC
NTRA
NTRA
Q4 25
38.7%
5.4%
Q3 25
10.4%
3.8%
Q2 25
8.9%
4.7%
Q1 25
10.2%
4.3%
Q4 24
53.1%
3.8%
Q3 24
12.6%
3.7%
Q2 24
11.0%
2.8%
Q1 24
12.6%
5.5%
Cash Conversion
DHC
DHC
NTRA
NTRA
Q4 25
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons